Summary
The European Parliament has approved an extension for the use of a specific chemical group essential for COVID-19 vaccines and diagnostic kits. 9 16.12.2020
Other
health
science
environment
public administration
Key points
- The chemical substance group meets specific criteria for regulatory oversight.
- This chemical is vital for the production of COVID-19 vaccines and diagnostic medical tools.
- The measure ensures that the use of these substances for medical research and production remains legally valid.
- The deadline to submit applications for authorization is postponed by 18 months after the regulation takes effect.
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.